Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

Pfizer’s Paxlovid and Merck & Co’s Molnupiravir are two oral antiviral treatments authorised for patients with mild to moderate COVID-19 symptoms at a high risk of developing severe illness.

Recognizing symptoms like cough, fever, and difficulty breathing is crucial for timely medical intervention, which may ...

In 2023, Russia supplied over $72 million worth of pharmaceutical products to Africa. The main buyers of Russian drugs are Nigeria, Uganda, Algeria, Congo and Morocco. The chief products are yellow ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

Over the recent years, a positive impact has been seen on the growth of the market. Since biopharmaceutical innovators are at ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

Scientists monitor mpox virus mutations and human-to-human transmission, impacting vaccination strategies in Africa.

The first presumptive human case of avian bird flu has been found in Canada. Here’s what you need to know about avian flu.

It’s true, even the common cold hits differently when you’re expecting. Not only can symptoms be more intense—and annoying, ...

Blood tests have shown that about 7 per cent of workers on dairy farms that had H5N1 outbreaks had antibodies against the ...